Articles

Some scientists use cancer patients as libraries for discovering novel immunotherapies.

In the 21^st century, viral spillovers will become more and more common. We are not in the dark and can prepare now for new breakouts before they even begin.

New inhibitors specific for gonorrhea enzymes may pave the way to treating multi-drug resistant infections.

Cancer cells acquire new skills to break free of their environmental constraints and  spread to new locations in the body.

A new oral delivery system may replace injections for people with diabetes.

Scientists identified two proteins that help Lyme bacteria evade detection by the human complement system, paving the way for new therapeutics and vaccine targets.

A bacterial inhibitor enhances conventional antibiotics by killing Staphylococcus aureus and stopping a communication system in Pseudomonas aeruginosa.

Researchers around the world are on a mission to bank biological samples from millions of people. So far, these efforts have disclosed the effects of arsenic exposure on the genome, supported development of early cancer diagnostics, and even revealed the ideal timing for COVID-19 boosters.

In a journey that spanned the genomes of more than 150,000 Icelanders, archival samples, and a fetus in utero, researchers not only identified genetic variants missing from the population, but also proved that these missing mutations cause three rare genetic diseases.

Researchers simultaneously increased the potency of a cancer drug while reducing both the required dose and the side effects, all by using a surprising new drug delivery vehicle: bacteria.